Agilon Health, Inc. (NYSE:AGL) Short Interest Down 94.9% in March

Key Points

• Short interest plunged 94.9% in March to 1,357,594 shares (about 8.4% of shares sold short), leaving a days-to-cover ratio of 7.1 based on average daily volume.
• Shares traded around $19.01 with a market cap of $315.3M; the company reported quarterly revenue of $1.57B (above estimates) but missed EPS at ($0.46) and shows negative return on equity and net margin.
• Analyst sentiment is mixed with a MarketBeat consensus of Hold (average target $50.20) after varied price-target changes, while a handful of institutional investors recently built small stakes.

Agilon Health, Inc. (NYSE:AGL - Get Free Report) saw a significant drop in short interest in the month of March. As of March 31st, there was short interest totaling 1,357,594 shares, a drop of 94.9% from the March 15th total of 26,654,381 shares. Based on an average daily volume of 191,813 shares, the days-to-cover ratio is presently 7.1 days. Approximately 8.4% of the shares of the company are sold short.

Agilon Health Stock Performance

Shares of Agilon Health stock traded down $0.83 during midday trading on Friday, hitting $19.01. The company had a trading volume of 338,889 shares, compared to its average volume of 269,538. The business's 50 day simple moving average is $13.30 and its two-hundred day simple moving average is $18.03. The stock has a market cap of $315.31 million, a PE ratio of -0.80 and a beta of 0.33. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. Agilon Health has a 1-year low of $7.48 and a 1-year high of $144.25.

Agilon Health (NYSE:AGL - Get Free Report) last posted its quarterly earnings results on Wednesday, February 25th. The company reported ($0.46) earnings per share for the quarter, missing analysts' consensus estimates of ($0.27) by ($0.19). Agilon Health had a negative return on equity of 120.82% and a negative net margin of 6.60%.The business had revenue of $1.57 billion for the quarter, compared to analyst estimates of $1.46 billion. As a group, equities analysts predict that Agilon Health will post -0.59 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on AGL. Benchmark lifted their price target on shares of Agilon Health to $13.00 and gave the company a "buy" rating in a research report on Thursday, April 2nd. Weiss Ratings reissued a "sell (e+)" rating on shares of Agilon Health in a research report on Wednesday, January 21st. BTIG Research reissued a "neutral" rating on shares of Agilon Health in a research report on Friday, December 12th. Deutsche Bank Aktiengesellschaft set a $33.00 price objective on shares of Agilon Health and gave the stock a "hold" rating in a research note on Thursday. Finally, Barclays lowered their price objective on shares of Agilon Health from $25.00 to $12.50 and set an "underweight" rating on the stock in a research note on Friday, February 27th. Three equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have assigned a Sell rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $50.20.

Institutional Investors Weigh In On Agilon Health

A number of institutional investors have recently bought and sold shares of AGL. Wealthcare Advisory Partners LLC acquired a new stake in shares of Agilon Health in the 3rd quarter valued at $26,000. LPL Financial LLC raised its holdings in shares of Agilon Health by 213.4% in the fourth quarter. LPL Financial LLC now owns 44,055 shares of the company's stock valued at $30,000 after buying an additional 30,000 shares during the last quarter. Krilogy Financial LLC bought a new position in shares of Agilon Health in the fourth quarter valued at about $34,000. CIBC Bancorp USA Inc. bought a new position in shares of Agilon Health in the third quarter valued at about $34,000. Finally, Merit Financial Group LLC bought a new position in shares of Agilon Health in the fourth quarter valued at about $35,000.

Agilon Health Company Profile

Agilon Health NYSE: AGL is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.